Interested to see how the quarterly report will impact everyone's view on the company. I didn't see the logic behind this stock being in the $40 range before acquiring HIVE and now that they have it the pps has been $2-5.
These penny stocks almost always 'create' more value on hype and anticipation rather than facts. Even if a product meets all sales expectations it doesn't ever seem to boost pps to those hype levels.
Having said that, I do think based on actual product sales and share structure that this stock is currently undervalued, but due to the typical reaction I don't see $10+ immediately. Its almost like before it was a game where you could see violent 50% swings up or down based on nothing (no news, etc.) but now that the reality has set in (real company with product being moved) VAPE will begin behaving like a real ticker. Traders like to play on people's emotions and it's easy to make money by causing fear and doubt or to tout like crazy during development phases; thats where these guys make their money whether they are buying or shorting.
Sales will grow, more products and outlets will yield higher revenue and the leadership will dictate how liabilities are managed given their assets. That, in the long run, is what can turn this back into a real $20+ stock.
News 
Market Data 
Discover 
AI
